About Wessex AHSN
Centre for Implementation Science
Frequently asked questions
AdviSeME Prize - Competition to find a transformative medical product
NICE Scientific Advice recently launched a competition, the NICE AdviSeME Prize, to find a transformative medical product in the early stages of de...
Precision Cancer Medicine: Forefront Technologies at the Clinical Interface, 14th September 2017
Newsletters, annual reports...
The Atrial fibrillation programme has 3 aims. To detect AF; to perfect treatment of patients with AF and; to protect people with AF from stroke. To achieve these aims we have a broad programme of work.
Over the past year, the programme has seen fantastic engagement and results in its work to reduce stroke across Wessex through the use of anticoagulants in treating Atrial Fibrillation. There is a thriving network and an education programme aimed at pharmacists and GP's. The programme has delivered a 67% increase in anticoagulant prescribing across Wessex, with 60% of providers showing a reduction in stroke plus a 17% reduction in the variation in exception reporting.
We have a PRIMIS facilitator in post, who is able to help practices to set up and run GRASP AF and Warfarin Patient Safety Audits, to identify patients who need treatment reviews. In West Hampshire CCG’s area, supported by the AHSN, 51 practices were supported to use PRIMIS audit tools to identify at-risk patients and, as a consequence, demonstrated a reduction of 47 strokes in eight months, saving the NHS (an estimated) £2m.We have been sucessful in getting our work noticed, being shortlisted for HSJ Value in Healthcare award in 2016 and an HSJ Patient Safety Award in 201. It won a Quality in Anticoagulation award for the development of nurse-led anticoagulation services with Salisbury NHS Trust. Starting Anticoagulation with Jack is a short film for patients about Anticoagulation, developed with the Royal Pharmaceutical Society, Voluntary organisations and patient groups. We also have a short film about our outreach work between hospital and primary care showing how we're working together to improve anticoagulation in atrial fibrillation in the community.
Anticoagulants are prescribed to prevent harmful blood clots that can lead to stroke. They are designed to prevent or treat clots, but can increase the risk of bleeding. Patients and carers need advice and information about how these medicines wor...
Find out more >
West Hampshire CCG
South Eastern Hampshire CCG
Portsmouth Hospitals NHS Trust
Hampshire & IOW LPC
Hampshire Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
What is the concern about Atrial Fibrillation (AF)? By Sharron Gordon, Pharmacist Consultant Anticoagulation, Faculty Fellow of The Royal Pharmaceutical Society and Wessex AHSN AF leadAtrial Fibrilla...
Warfarin patient information leaflet
NOAC patient information leaflet
Checklist for patient counselling on oral anticoagulant therapy
DOAC Alert Card
NOAC Patient Information Sept. 2016
NMS Card Newsletter Jan 2017
NMS Referral Card
Atrial Fibrillation Newsletter January 2017
AF programme impact flashcard 2016-17
AF Business Case Modelling Tool
Read more >